Pulmonary Fibrosis Treatment : PivotalHealth.info

Attention: Pulmonary Fibrosis Patients

Attention People Suffering from Pulmonary Fibrosis:

If you are suffering from Pulmonary Fibrosis we encourage you to try our Pulmonary Fibrosis Package. Users that have started with these products have reported results almost immediately. With a 95% success rate for people using the Pulmonary Fibrosis product package, users are reporting that even within in the first 2 weeks that they are seeing a improvement in breathing, less mucus build up and their energy levels are increasing. If you have had Pulmonary Fibrosis for years or if you have just been diagnosed the products we offer will have a positive impact in your fight against Pulmonary Fibrosis. Don't just take our word for it, Janice from Sacramento, CA writes"

Robert Cameron                                           January 18th, 2010

Having concluded 8 weeks on recommended products, I am excited to report the following improvements to my general health.

1. Annoying cough has almost gone
2. Mucus has decreased by 80%.
3. Increase in oxygen level in blood and ability to take deep breaths.
4. Increase in energy and ability to do extra ecercise. My 6 minute walk has increased to 20 minutes and am now able to do some cardio exercises.
5. Weight loss has stopped and have actually put back on 2kg.

I intend staying on the full Thereapeutic Phase for 20 weeks as this is definitely working for me. Also people say that I am looking well -even my Lung Specialist!!
Thank you Pivotal Health

Janice                                                                                 September 4th 2009

"Pivotal Health, I am a 63 yr old female that was diagnosed with Pulmonary Fibrosis about a year and a half ago. Not knowing what to do I took my doctors advice and I did exactly what he said to do. After one year he explained that my condition was getting worse and that I now need to be on oxygen. As you can imagine I was very frustrated to learn that I was not getting any better. Around June my son decided to see what my other options were, after a lot of research on the internet I came across pivotal health's website and their pulmonary fibrosis information. I called pivotal health after looking around the internet to see what other people dealing with pulmonary fibrosis were doing to stop this condition.   As you may know there isn't many options available for people with my condition.   I spoke with Troy at Pivotal Health and he was very knowledgeable and very helpful. He told me that he talks with Pulmonary Fibrosis patients everyday, and that the product package they offer is 95% successful to people taking it. I must say after after 2 weeks on these products I couldn't believe I was able to take deep breaths again, my mucus is almost completely gone and I have cut down on the use of my oxygen machine considerably. I have know been on the products coming up on 3 months I no longer use oxygen at all, my doctor could not believe my last chest scan, that showed my scar tissue in my lungs was reduced by almost 60%. My advice to anyone out there that is looking for hope and feels like they don't have any more options, is to call Pivotal Health. That one call changed my life.

Thank you so very much,
Janice 9/4/09

Pulmonary Testimonial                                                                              September 15, 2009

I was diagnosed with pulmonary fibrosis over 4 years ago and my doctor gave me 3 years to live. I was coughing constantly and I had a lot of inflammation. I decided to not give up so, I went online and found an enzyme with the sebkinase blend in it. I began taking it and after 1 month my coughing was pretty much gone and I started improving more and more everyday. I have now been taking the sebkinase blend for over 4 years and my doctors are stumped that I show very little evidence of my pulmonary fibroses and I feel great! I wanted to do this testimonial for Troy at Pivotal Health in hopes that this will help others with pulmonary fibrosis and to let them know that there is help available. I take Serracor NK everyday and I will continue to do so for the rest of my life. Don't give up hope this product will help you.

Thanks again Troy

Haywood L.

To Pivotal Health & Troy                                                                    Oct 6, 2009

We heard about Serracor-NK from a friend who had a heart attack and was told he would need bypass surgery.

He did research and found this product he started taking it and when he went back to the cardiologist in 6 months he was told that they could not find any blockage in his heart or his heart arteries. He has continued to take this product and says he will keep taking it. Our experience with this product is that Cody has had triple bypass surgery and had high blood pressure. When Tony told Cody and I about this product we came home and ordered some and Cody has been taking it for 5 months in July we went to see Codys cardiologist and he told him that he was doing well and to keep doing what ever he was doing because it was working. His blood pressure has gone down and he has recently also had blood work done and his numbers are all normal which they were not last time they were done. We feel that this is due in large to him taking this product. He will be continuing to take it long term. Thanks Pivotal Health for a great product.

Debbie

Pulmonary Fibrosis Links

We now have down loadable information and message board please use the link below:

Pulmonary Fibrosis Chart
1. To view the Pulmonary Fibrosis time line chart please click here.

Pulmonary Fibrosis Flyer
2. To down load our Pulmonary Fibrosis flyer please click here.

Pulmonary Fibrosis and Enzyme Therapy Article
4. To read our article on Enzyme Therapy and it use for Pulmonary Fibrosis please click here

Message Board

4. We also now have a free message board were you can asks questions from our enzyme specialist, read other users feedback and share your experiences with other users please click the link below to go to our message board.Message board link please click here

What is Pulmonary Fibrosis?

" Fibrosis" is a term used to refer to scarring, so pulmonary fibrosis means scarring throughout the lungs. Pulmonary fibrosis can be caused by many conditions including chronic inflammatory processes (sarcoidosis, Wegener's granulomatosis ), infections, environmental agents (asbestos, silica, exposure to certain gases), exposure to ionizing radiation (such as radiation therapy to treat tumours of the chest), chronic conditions (lupus, rheumatoid arthritis), and certain medications.

In a condition known as hypersensitivity pneumonitis, fibrosis of the lung can develop following a heightened immune reaction to inhaled organic dusts or occupational chemicals. This condition most often results from inhaling dust contaminated with bacterial, fungal, or animal products.

In some people, chronic pulmonary inflammation and fibrosis develop without an identifiable cause. Most of these people have a condition called idiopathic pulmonary fibrosis (IPF) that does not respond to medical therapy, while some of the other types of fibrosis, such as nonspecific interstitial pneumonitis (NSIP), may respond to immune suppressive therapy.

Synonyms (other names) for various types of pulmonary fibrosis that have been used in the past include chronic interstitial pneumonitis, Hamman-Rich Syndrome, and diffuse fibrosis alveolitis. Symptoms of pulmonary fibrosis include shortness of breath, coughing and diminished exercise tolerance. The severity of symptoms and the progression (worsening) of symptoms over time can vary and are at least partially dependent upon the cause of the fibrosis.

Pulmonary fibrosis is suggested by a history of progressive (worsening over time) shortness of breath with exertion. Sometimes, during examination of the lungs with a stethoscope, the doctor can hear crackling sounds in the chest. The chest x-ray may or may not be abnormal, but a special x-ray test called a high resolution CAT scan will frequently demonstrate abnormalities. Lung function testing is distinctly abnormal.

The diagnosis can be confirmed by lung biopsy. An open surgical biopsy, meaning that the chest wall must be surgically opened under general anesthesia to remove a portion of lung tissue, may be necessary to obtain enough tissue to make an accurate diagnosis. The removed tissue is examined microscopically by a pathologist to confirm the presence of fibrosis.

The treatment options for idiopathic pulmonary fibrosis are very limited. There is no evidence that any medications can help this condition, since scarring is permanent once it has developed. Lung transplantation is the only therapeutic option available. At times, this diagnosis can be difficult to make even with tissue biopsy reviewed by pathologists with specific experience in this field. Research trials using different drugs that may reduce fibrous scarring are ongoing. Since some types of lung fibrosis can respond to corticosteroid (such as Prednisone) and/or other medications that suppress the body's immune system, these types of drugs are sometimes prescribed in an attempt to decrease the processes that lead to fibrosis.

The immune system is felt to play a central role in the development of many forms of pulmonary fibrosis. The goal of treatment with immune suppressive agents such as corticosteroid is to decrease lung inflammation and subsequent scarring. Responses to treatment are variable. Once scarring has developed, it is permanent. Those whose conditions improve with immune suppressive treatment probably do not have idiopathic pulmonary fibrosis.

The toxicity and side effects of treatments can be serious. Therefore, patients with pulmonary fibrosis should be followed by a lung specialist experienced in this condition. The lung specialist will determine the need for treatment, the duration of treatment, and will monitor the response to therapy along with any side effects. Only a minority of patients respond to corticosteroid alone, so other immune-suppressing medications are used in addition to corticosteroid. These include gamma-interferon, cyclophosphamide, azathioprine, methotrexate, penicillamine, and cyclosporine. The anti-inflammatory medication colchicine has also been used with limited success. Ongoing trials are underway using newer drugs such as gamma interferon, mycophenolate mofetil (Cellcept), and pirfenidone.

Pulmonary fibrosis can cause decreased oxygen levels in the blood. A decrease in blood oxygen level (hypoxia) can lead to elevated pressure in the pulmonary artery (the vessel that carries blood from the heart to the lungs to receive oxygen), a condition known as pulmonary hypertension, which can in turn lead to failure of the right ventricle of the heart. Therefore, patients with pulmonary fibrosis are frequently treated with supplemental oxygen to prevent pulmonary hypertension.

There is also evidence that patients suffering from pulmonary fibrosis may be at increased risk for blood clots that travel to the lung (pulmonary emboli), and therefore anticoagulant (blood thinning) therapy may be indicated.1

Attention Pulmonary Fibrosis patients SERRACOR-NK the origanal SEBkinase blend is being used by people suffering from: Pulmonary Fibrosis, Lung Disease, Intersitial Lung Disease, Scarring of the Lungs

SERRACOR-NK can help with Pulmonary Fibrosis by:

Act as cellular detoxifiers to remove toxins in lung cells.
Boosting your bodies natural immune system response.
Dissolve fibrin and scar tissues in the lungs.
Improve lung function and lung flexibility.
Improve breathing and reduce coughing

Serracor-NK is formulated specifically to dissolve Fibrin (scar tissue) through out the body and in the blood stream. Serracor-NK accomplishes this with its two main active ingredients serrapeptase and nattokinase. These two systemic enzymes dissolve fibrin by attaching them selves to the fibrin by a lock and key type action that releases the proteolytic based enzymes of fibrin. When this sequence takes place the fibrin is broken down into enzyme form and then released from the body through sweat, urine and feces. When the build up of fibrin in the lung area starts to dissolve your body immune system will then be able to reach the lungs and begin the healing process. Since a high percentage of people suffering from Pulmonary Fibrosis have developed this condition over many years, the amount of time to be on Serracor-NK varies from person to person. It is strongly suggested that users of Serracor-NK follow the Pulmonary Fibrosis dosage chart and can expect to be on this product from a period of 4-12 months. We have received a strong response from our customers stating that within the first 30 days they have noticed increased airflow and better capability breathing. From the 30-90 day range Serracor-NK users report a significant improvement in breathing, reduction of coughing and mucus, and in some patients the discontinuing of assisted breathing machines or oxygen tanks. We at Pivotal Health have seen first hand the miraculous benefits of Serracor-NK for Pulmonary Fibrosis. We have also formulated a product package with Serracor-NK to help with increasing the fibrin breakdown (Serra RX80) and to dissolve and discard mucus in the lung area (Clear lungs). If you have mucus build up Clear Lungs will help with 99% of the mucus in the lungs along with the bacteria that mucus causes. Please read our dosage chart below to see how to help yourself with Serracor-NK.

Please scroll below to order these products or if you have any questions or would like to order by phone

please call 1-877-404-8804.

If you would like to view our Pulmonary Fibrosis time line chart to see what you can expect from our Pulmonary fibrosis package please click here.

Pulmonary Fibrosis

A new approach against Pulmonary Fibrosis?

Eat Away Pulmonary Fibrosis Scar Tissue:

Pulmonary Fibrosis literally means lung (pulmonary) scarring (fibrosis). The lung scarring occurs in the tissue of the lung called the interstitium, which supports the structures of the lung (air sacs/alveoli). There are an estimated 130-200 related diseases called Interstitial Lung Disease that are similar in characteristics and can result in scarring. Pulmonary Fibrosis causes the lung tissue to thicken and become stiff. Scarring inhibits oxygen from entering the blood stream. 2

The research behind Enzyme Therapy for Pulmonary Fibrosis?

Serrapeptase has been in use since 1979. Since then the effacous anti-inflammatory response with the use of Serrapeptase has been shown not only as new way to eliminate fibrin or fibrous formations in the body systemically but is showing promising results for Chronic inflammation in the lungs along with the dispelling of mucus in the lining of the arterial walls in the lungs. Studies have shown the positive effects of Serrrapeptase for the use of Pulmonary Fibrosis.

Systemic Enzyme Therapy for Pulmonary Fibrosis

What is Systemic Enzyme Therapy?

People must know that the correct medical name for the therapeutic use of natural enzymes is "Systemic Enzyme Therapy." This means that enzymes flow throughout our body, producing the desired healing effects. For an accurate description of Systemic Enzyme Therapy, one needs to know a little bit about the structure and function of enzymes, in general. You must know that without enzymes, there is no possibility of life, in animals, plants or persons. Enzymes are essential for each and every reaction in a living organism.

Enzymes are catalysts, or rather we should say, "biolcatalysts." We are dealing with determined substances whose presence causes the transformation of an organic substance and it also accelerates it, just as a catalyst would do it. Today we know what these enzymes are and how they act.

At the Program for Studies of Alternative Medicines of the University of Guadalajara (Mexico), we have researched the therapeutic value of these natural proteolytic enzymes in the treatment of acute and chronic clinical conditions. We have had the opportunity of reaffirming that enzymes are catalytically active polymer compounds made of amino acids. They are involved in virtually all of the vital metabolic processes. They set metabolic conversions in track (in train), control energetic processes and regulate syntheses. Without enzymes, nothing goes on at all within an organism.

It is therefore normal to use enzymes for therapeutic purposes. Substitution in intestinal enzyme deficiency conditions is a classical treatment modality that no one would dispute. External use of enzymes for impaired wound healing (e.g. in the presence of varicose ulcers) has been part of the armamentarium of medical practitioners for centuries.

After many years of experience in analysis and pharmaceutical areas, it was thought that these powerful enzymes could be used in the therapeutic field, too. This way, a new area of enzymatic therapy began. It was applied to alleviate disturbances in the metabolism, that is, impairments in the functions of the organs and to repair genetic faults.

Soon scientists concluded, thanks to these new biochemical tools, that the genetic defects could be corrected or neutralized by means of the application of enzymes. Besides, the genetic defects are enzymatic defects. So far there have been reported in the medical literature more than 150 diseases that are due to enzymatic faults genetically conditioned. This means that the patient's organism does not form a specific enzyme or it manufactures and places a similar enzyme which has only weak activity. This weak enzyme replaces the right one.

Systemic Enzyme Therapy and its use for Inflammation?

Enzymes are not anti-inflammatory drugs, instead, they promote the inflammation; this is, inflammation is the marvelous response from our body to a noxious stimulus. Most times we look at inflammation as something bad and to be avoided. It should not be so. It is the way our body is trying to get rid of the harmful foreign agents.

The classical signs of inflammation are; pain, tumor, heat and blush. When inflammation ends, the body repairs the area affected. So, if the inflammation finishes sooner, then the repair will begin earlier. That's the reason why enzymes are promoters instead of inhibitors of inflammation.

Systemic enzyme therapy is a proven method; it diminishes the edema, activates the fibrinolytic system, and stimulates cells like macrophages. The pain and the cramps disappear, swelling goes away, and blood flow increases in a short time. The efficacy of certain enzyme mixtures has been tested by double-blind studies.7,8

SERRACOR-NK and Systemic Enzyme Therapy

The formulation:

SERRACOR-NK (SEBkinase) is formulated by the #1 enzyme supplier to the world Specialty Enzymes. They cultivate their own enzymes in a 200 million dollar enzyme manufacturing facility. Once the enzymes pass the many stringent testing qualifications they are then bio fused together into formulations by a team of enzyme researchers and doctors to have the highest enzymatic effect within the body for that specific formulation. Specialty Enzymes has been formulating enzymes formulations for over 75 years and has been the leader in not only the highest quality enzymes but many of the effective enzyme formulations you seen on the market to date. SERRACOR-NK (SEBkinase) is Specialty Enzymes newest formulation (SEBkinase) a fibrin dissolving systemic enzyme blend that will effectively eliminate fibrosis and C-reactive protein within the body. In fact this same exact enzyme formulation has been available for the last 5 years. Now the SEBkinase blend is only being sold under the product name SERRACOR-NK . This unique formula contains PeptizymeSpecialty Enzymes own trademarked serrapeptase.

Peptizyme SP is formulated for maximum fibrinolytic activity. Fibrin is a tough protein arranged in long fibrous chains. It is formed from fibrinogen, a soluble protein that is produced by the liver and found in blood plasma. Peptizyme SP supports normal fibrin metabolism, thus reducing viscosity and aiding normal blood flow. Fibrin tends to form circulating complexes that build a wall of fibrin around areas of inflammation, creating a barrier for the uptake of healing nutrients. In addition Peptizyme SP supports healthy inflammatory response by reducing metabolic inflammation, usually an asymptomatic inflammatory process in response to stress, improper nutrition and other environmental insults. There is also evidence of inhibition of C-Reactive Protein, a marker for inflammation that has been linked to cardiovascular health. 22a, 22b

SERRACOR-NK (SEBkinase) also contains NattoSEB [Nattokinase], also Specialty Enzymes own trademarked and formulated Nattokinase. NattoSEB recently a new enzyme with potent fibrinolytic activity that rivals pharmaceutical agent has been discovered and shows great potential in providing support for hyper coagulative states. This all-natural enzyme, NattoSEB [Nattokinase], is derived from fermented soy and the bacteria Bacillus Natto. Already, backed by research, NattoSEB [Nattokinase] shows promise in supporting areas such as cardiovascular disease, stroke, angina, venous stasis, thrombosis, emboli, atherosclerosis, fibromyalgia/chronic fatigue, claudication, retinal pathology, hemorrhoid, varicose veins, soft tissue rheumatisms, muscle spasm, poor healing, chronic inflammation and pain, peripheral vascular disease, hypertension, tissue oxygen deprivation, infertility, and other gynecology conditions (e.g. endometriosis, uterine fibroids).

Both Peptizyme SP (serrapeptase) and NattoSEB (nattokinase) are enterically coated and are formulated to an exact milligram for optimal performance in this blend. Digestive enzymes (DigeSEB) are also used in the SEBkinase formula, there purpose is to aid in the enhancement of the formula and should not be taken strictly as a digestive supplement. The last ingredient in SERRACOR-NK (SEBkinase) is Co-Q10 this is in the formula not only as a coenzyme, but to complement the strong cardiovascular benefits of SERRACOR-NK (SEBkinase) 23

How can SERRACOR-NK (SEBkinase) can help for Pulmonary Fibrosis?

SERRACOR-NK (SEBkinase) is a gaining popularity and becoming a promising supplement for people suffering from the harmful and life threatening effects of Pulmonary Fibrosis. SERRACOR-NK (SEBkinase) has encouraging outcome for people suffering from Pulmonary Fibrosis. The combination of Serrapeptase and Nattokinase in SERRACOR-NK (SEBkinase) are formulated to break up fibrinogen and lower the body's anti-inflammatory response. The use of systemic enzymes for Pulmonary Fibrosis is a new approach to combat the fibrin build up in the arterial lining within the lung walls. By reducing the fibrin levels within the lungs a synergistic effect is also created by the SERRACOR-NK (SEBkinase) formula, improve immune function. By removing the fibrin from the lungs your body's inflammation marker will drop resulting in improved immune function which in turn allows the body's natural healing process to begin. A secondary function on SERRACOR-NK (SEBkinase) is the decreased amount of mucus to be harnessed in the lungs. As mucus levels drop so will the bacteria and infection within the lung membranes. Fibrin being a major cause to reduction of airflow and by reducing the infection of bacteria in the lungs, users will start to have an improvement of airflow, reduction of mucus, improved energy and an overall improvement in their body's immune response.

SERRACOR-NK (SEBkinase) is an important step in the fight against Pulmonary Fibrosis. Users should always consult with a doctor before taking any supplement and also taking prescribed pharmaceuticals. SERRACOR-NK (SEBkinase) should not be taken with any blood thinning medication. SERRACOR-NK (SEBkinase) does thin the blood and users should always discontinue the use of SERRACOR-NK (SEBkinase) if your are taking any blood thinning medications.9

Serracor-NK Precautions:

Serracor-NK® is not recommended for women that are pregnant or nursing, as these groups have not been clinically tested. Anemic women with heavy periods should take Serracor-NK® with caution, as additional bleeding can occur.Do not take Serracor-NK® if your fibroids are causing immediate health concerns, or if you are currently taking blood thinning medication. As always consult with your doctor before taking Serracor-NK®.

As you begin to take Serracor-NK® toxins and other debris will be expelled from your system.We refer to this process as enzymatic detoxification. Symptoms such as fatigue, upset stomach, headaches, and diarrhea may occur. If at any point you start to feel ill you may be detoxifying too quickly. Decreasing your dosage for a more gradual and comfortable detoxification period is therefore recommended. It may take several days to completely cleanse the body of unwanted toxins. Enzymatic detoxification is only temporary, and in the most extreme cases may last up to a period of 14 days.

3-6 month Pulmonary Fibrosis Program

Attention customers: it is vitally important that you stay on this program for a minimum of 3 months. This will insure that your body builds up efficient enzyme levels that will aid in the breakdown of scar tissue, inflammation, mucus and start the healing process. You should continue to take this product for the full length of this program for optimal results. Maintence phase is highly suggested to stop the future formation of scar tissue in the lungs.

To download our Pulmonary Fibrosis Article please click here